Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

TRPV1 antagonists

US Patent 8604053 · Granted Dec 10, 2013

Estimated economic value: $237,163,000

Assignee

Inventors

View full patent text on Google Patents →